Axogen prices 4,910,000-share follow-on offering at USD 42.5 per share

• Axogen priced an underwritten public offering of 4,910,000 common shares at USD 42.5 per share.
• Gross proceeds expected at about USD 208.7 million, excluding any exercise of the underwriters’ option.
• Underwriters hold a 30-day option to buy up to 736,500 additional shares.
• Closing expected on Sept. 11, 2026, subject to customary closing conditions.
• Net proceeds earmarked primarily to fund cash consideration for the planned BioCircuit Technologies acquisition, with any remainder for general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Axogen Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609100601PRIMZONEFULLFEED9824379) on September 10, 2026, and is solely responsible for the information contained therein.